胰岛素依赖型糖尿病患者因慢性肢体威胁性缺血首次下肢血运重建后的结局
本研究回顾了2005至2014年本机构580例胰岛素依赖型糖尿病合并慢性肢体威胁性缺血患者的655条肢体首次血运重建记录,比较旁路移植术与经皮腔内血管成形术±支架的结局。旁路移植术组围术期并发症无差异,但6个月伤口未愈合率、5年再狭窄率和再干预率更低;校正后经皮腔内血管成形术±支架与再狭窄和再干预风险升高相关,逆概率加权后结果稳健。作者认为旁路移植优先策略可能最适合解剖合适的患者。
要点
- 胰岛素依赖型糖尿病合并慢性肢体威胁性缺血患者中,旁路移植术组与经皮腔内血管成形术±支架组围术期并发症无显著差异。
- 旁路移植术组未校正6个月伤口未愈合率49% vs 57%,5年再狭窄率53% vs 72%,再干预率47% vs 58%。
- 校正后经皮腔内血管成形术±支架与再狭窄风险升高相关(HR 1.9,95%CI 1.3-2.7),逆概率加权后结果稳健。
核心结论
- 在胰岛素依赖型糖尿病合并慢性肢体威胁性缺血患者中,旁路移植优先策略与相似的30天结局相关,且再狭窄率和再干预率更低。
- 作者认为旁路移植优先策略可能最适合经适当选择、解剖合适且需血运重建的足部缺血患者。
研究设计与样本
- 回顾性队列研究,纳入2005至2014年本机构因慢性肢体威胁性缺血接受首次腹股沟下旁路移植术或经皮腔内血管成形术±支架的胰岛素依赖型糖尿病患者。
- 共655条肢体(旁路移植术316条,经皮腔内血管成形术±支架339条)来自580例患者符合标准。
- 采用χ2检验、Kaplan-Meier法和Cox回归比较两组结局,并以倾向性评分和逆概率加权作为敏感性分析。
主要发现
- 旁路移植术组与经皮腔内血管成形术±支架组年龄(69 vs 68岁,P=0.55)、组织缺损率(87% vs 91%,P=0.07)、透析依赖率(26% vs 28%,P=0.55)、平均糖化血红蛋白(8.1% vs 8.0%,P=0.51)和平均空腹血糖(158 vs 150 mg/dL,P=0.18)无显著差异。
- 旁路移植术组高血压比例较低(84% vs 92%,P<0.001),当前吸烟比例较高(21% vs 14%,P=0.02)。
- 旁路移植术组总住院时间显著更长(11 vs 8天,P<0.001),但围术期并发症无差异,包括急性肾损伤(19% vs 23%,P=0.24)、血肿(6.0% vs 3.8%,P=0.20)、急性心肌梗死(1.3% vs 2.1%,P=0.43)和死亡(3.8% vs 3.0%,P=0.55)。
- 旁路移植术优先组未校正6个月伤口未愈合率显著更低(49% vs 57%),5年再狭窄率(53% vs 72%)和再干预率(47% vs 58%)也显著更低(均P<0.05)。
- 校正后多变量分析提示经皮腔内血管成形术±支架优先干预与再狭窄风险升高显著相关(HR 1.9,95%CI 1.3-2.7)和再干预风险升高显著相关(HR 1.9,95%CI 1.2-2.7),逆概率加权后结果稳健。
临床怎么用
- 作者认为旁路移植优先策略可能最适合经适当选择、解剖合适且需血运重建的足部缺血患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Historically, open surgical bypass provided a durable repair among diabetic patients with chronic limb-threatening ischemia (CLTI). In the current endovascular era, however, the difference in long-term outcomes between first-time revascularization strategies among patients with insulin-dependent diabetes mellitus (IDDM) is poorly understood. METHODS: We reviewed the records of all patients with IDDM undergoing a first-time infrainguinal bypass graft (BPG) or percutaneous transluminal angioplasty with or without stenting (PTA/S) for CLTI at our institution from 2005 to 2014. We defined IDDM as use of chronic insulin administration at baseline to control blood glucose levels and recorded the most recent glycated hemoglobin value available within 3 months before the procedure and fasting blood glucose level on the day of the procedure. We compared rates of wound healing, restenosis, reintervention, major amputation, and mortality between BPG and PTA/S in our population using χ2, Kaplan-Meier, and Cox regression analyses. As a sensitivity analysis, we calculated propensity scores and employed inverse probability weighting to account for nonrandom assignment to BPG vs PTA/S. RESULTS: Of 2869 infrainguinal revascularizations from 2005 to 2014, 655 limbs (316 BPG, 339 PTA/S) in 580 patients fit our criteria and underwent a first-time revascularization for CLTI. Patients undergoing BPG, compared with PTA/S, were similar in age (69 vs 68 years; P = .55), had similar rates of tissue loss (87% vs 91%; P = .07) and dialysis dependence (26% vs 28%; P = .55), were less likely to be hypertensive (84% vs 92%; P < .001), and were more likely to be current smokers (21% vs 14%; P = .02). There were no differences between BPG and PTA/S patients in mean glycated hemoglobin levels (8.1% vs 8.0%; P = .51) or mean fasting blood glucose levels (158 vs 150 mg/dL; P = .18). Although total hospital length of stay was significantly longer among BPG patients (11 vs 8 days; P < .001), perioperative complications did not differ, including acute kidney injury (19% vs 23%; P = .24), hematoma (6.0% vs 3.8%; P = .20), acute myocardial infarction (1.3% vs 2.1%; P = .43), and mortality (3.8% vs 3.0%; P = .55). BPG-first patients had significantly lower unadjusted 6-month rates of incomplete wound healing (49% vs 57%) and 5-year rates of restenosis (53% vs 72%) and reintervention (47% vs 58%; all P < .05). After adjustment, multivariable analysis suggested PTA/S-first intervention to be significantly associated with higher risk of restenosis (hazard ratio, 1.9; 95% confidence interval, 1.3-2.7) and reintervention (1.9 [1.2-2.7]). These results remained robust after inverse probability weighting. CONCLUSIONS: Among patients with IDDM and CLTI, a bypass-first strategy is associated with similar 30-day outcomes and lower restenosis and reintervention rates. These data suggest that a bypass-first approach may best serve appropriately selected, anatomically suitable patients with IDDM and pedal ischemia that requires revascularization.
引用
- Darling JD, O'Donnell TFX, Deery SE, et al. Outcomes after first-time lower extremity revascularization for chronic limb-threatening ischemia in insulin-dependent diabetic patients. J Vasc Surg. 2018. PMID: 30360841. doi:10.1016/j.jvs.2018.01.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。